Subsequent Events (Details) - USD ($) |
1 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|
Jan. 07, 2020 |
Mar. 31, 2021 |
Jun. 22, 2020 |
Dec. 31, 2019 |
Jul. 31, 2020 |
|
Subsequent Events (Details) [Line Items] | |||||
Subsequent events, description | July 26, 2020 the Company consummated the acquisition of 100% of the shares of Jet CU, a company that was incorporated in Israel in May 2014 and was inactive on the purchase date since its operational assets were sold few years before. The main balance sheet items as of the purchase date were cash and liability to the Authority of approximately $0.8 million and approximately $1.0 million, respectively. The Company issued 2,000,000 ordinary shares and warrants to purchase 8,000,000 ordinary shares, at an exercise price of $0.26 per share as a consideration for the purchase. The warrants exercisable until the date which is the earlier of (i) 24 months as of the purchase date or (ii) Merger/Acquisition transaction or an IPO | ||||
Principal amount (in Dollars) | $ 4,775,555 | ||||
January 2019 through December 2020 [Member] | |||||
Subsequent Events (Details) [Line Items] | |||||
Increase in the percentage of raw materials | 50.00% | ||||
Board of Directors [Member] | Subsequent Event [Member] | |||||
Subsequent Events (Details) [Line Items] | |||||
Stock option (in Shares) | 15,607,995 | ||||
Stock option increase (in Shares) | 18,783,274 | ||||
Stock option granted | $ 13,739,570 | ||||
Stock option vested | minus 3 years | ||||
Exercise price | $ 0.068 | ||||
Forecast [Member] | |||||
Subsequent Events (Details) [Line Items] | |||||
Stock option granted | $ 939,164 | ||||
Stock option vested | minus 3 years | ||||
Exercise price | $ 0.068 | ||||
Principal amount (in Dollars) | $ 415,000 | ||||
Convertible loans (in Dollars) | 230,000 | ||||
Purchase price (in Dollars) | $ 1,625,000 | ||||
Conversion price | $ 0.17 | ||||
Forecast [Member] | Israeli [Member] | |||||
Subsequent Events (Details) [Line Items] | |||||
Interest rate | 4.00% | ||||
Forecast [Member] | One Investor [Member] | |||||
Subsequent Events (Details) [Line Items] | |||||
Convertible loan amount (in Dollars) | $ 16,748 |
X | ||||||||||
- Definition Aggregate Purchse Price No definition available.
|
X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. No definition available.
|
X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
X | ||||||||||
- Definition Raw materials increasing percentage. No definition available.
|
X | ||||||||||
- Definition Stock option increased. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The price per share of the conversion feature embedded in the debt instrument. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|